Today’s guest post comes from Carolyn Zele, Senior Manager of Solution Enablement at MMIT.
Carolyn describes how oncology pathways were developed to help standardize treatment and ensure quality care. She argues, however, that these pathways often shut manufacturers out of the market.
Click here to learn more about MMIT's Pulse Analytics solution, which provides insight into payer- and pathway-driven barriers to access.
Read on for Carolyn’s insights.
Read more »
Source: Post feed
